The Ivus Catheters Market has experienced significant growth in recent years, driven by increasing adoption of intravascular ultrasound as a gold-standard imaging modality for coronary and peripheral artery disease assessment. These specialized catheters integrate miniaturized ultrasound transducers at the distal tip, enabling real-time cross-sectional visualization of vessel lumen, wall morphology, and plaque characteristics during interventional procedures. Interventional cardiologists increasingly rely on IVUS to optimize stent sizing, assess lesion severity, and evaluate stent apposition and expansion.

The Ivus Catheters Market continues expanding due to rising complex coronary intervention volumes, growing evidence supporting IVUS-guided PCI improving clinical outcomes, and increasing peripheral vascular disease interventions. Manufacturers develop improved catheter designs including higher-frequency transducers for enhanced resolution, dual-frequency systems balancing penetration and detail, and integrated co-registration with angiography and optical coherence tomography. The market benefits from expanding operator training programs, favorable reimbursement for IVUS-guided procedures, and emerging applications in structural heart interventions including transcatheter aortic valve replacement planning.

Q: What drives growth in the IVUS catheters market? A: Complex PCI expansion, IVUS-guided intervention outcome evidence, peripheral artery disease growth, structural heart applications, and reimbursement support drive market growth.

Q: How does IVUS complement angiography in PCI? A: IVUS reveals lumen dimensions, plaque burden, calcium distribution, and stent expansion invisible on conventional 2D angiography, enabling optimized procedural results.

Q: What is the difference between IVUS and OCT imaging? A: IVUS provides deeper tissue penetration and better assessment of vessel remodeling; OCT offers superior resolution for stent strut visualization and superficial plaque characterization.